Welcome to our dedicated page for Oscar Health news (Ticker: OSCR), a resource for investors and traders seeking the latest updates and insights on Oscar Health stock.
Oscar Health Inc (OSCR) combines health insurance expertise with technology-driven solutions, offering individual plans, employer coverage, and Medicare Advantage programs. This news hub provides investors and healthcare stakeholders with timely updates on corporate developments shaping the digital health landscape.
Access official press releases and third-party analysis covering strategic initiatives, regulatory updates, and market positioning. Key focus areas include earnings announcements, partnerships with healthcare providers, technology innovations, and Medicare Advantage expansion efforts.
Our curated collection serves as a reliable resource for tracking OSCR's progress in simplifying healthcare through virtual care platforms and data-driven member services. Bookmark this page for streamlined access to financial disclosures, leadership updates, and operational milestones relevant to the evolving insurance sector.
Oscar Health, Inc. (NYSE: OSCR), a prominent healthcare technology company, is set to release its financial results for the second quarter of 2024 on Wednesday, August 7, 2024, before the market opens. Management will hold a conference call to discuss the results starting at 8:00 AM (ET). The live call can be accessed by dialing (888) 596-4244 using Conference ID 776-8132, and a webcast will be available. The call will also be archived on Oscar’s investor relations website for 90 days following the event.
Oscar Health, a healthcare technology company, will participate in the BofA Securities 2024 Global Health Care Conference. Chief Financial Officer, Scott Blackley, will present a business update on May 15, 2024. Interested parties can listen to the webcast on Oscar's investor relations website.
Oscar Health, Inc. announced its financial results for the first quarter of 2024, reporting total revenue of $2.1 billion, a 46% increase year-over-year. The company achieved positive net income of $177.4 million, with diluted earnings per share of $0.62. Key metrics like Medical Loss Ratio and SG&A Expense Ratio showed significant improvements. Adjusted EBITDA improved by $168.2 million year-over-year. The company reaffirmed its full-year 2024 outlook across all metrics.
FAQ
What is the current stock price of Oscar Health (OSCR)?
What is the market cap of Oscar Health (OSCR)?
